unaids4d
UNAIDS response to Gilead’s announcement on signing voluntary licensing agreements on lenacapavir with six generic manufacturers
We welcome Gilead’s statement of commitment to non-profit pricing, but we had been waiting eagerly for a specific price. We ...
unaids6d
UNAIDS statement on anti-LGBTQ+ legislation in Georgia
UNAIDS supports the UN Office for the High Commissioner of Human Rights' statement that these laws will “impose discriminatory restrictions on education, public discussion, and gatherings related to ...
unaids9d
The AIDS response is recognized as a beacon of hope and guide for revitalizing multilateralism at the 79th UN General Assembly
NEW YORK/GENEVA, 27 September 2024— At the 79 th United Nations General Assembly (UNGA79) and the Summit of the Future in New York, global leaders called for the revitalization of multilateralism to ...
unaids11d
Leaders pledge bold action to end AIDS by 2030
UNAIDS data shows that the end of AIDS as a public health threat is achievable by 2030, if countries, communities and partners close the gaps holding back progress.
unaids13d
Equity in the HIV response: Assessing progress and charting a way forward
As countries transition away from donor assistance and progress towards universal health coverage, there is growing emphasis on the importance of integrating HIV services into national health systems ...
unaids2d
Sam Kambarami Director, Finance and Accountability
Sam Kambarami is the Director, Finance and Accountability. He joined UNAIDS in September 2024 from the UN Climate Change/ United Nations Framework Convention on Climate Change (UNFCCC) secretariat ...
unaids5d
long-acting technologies
GENEVA, 2 October 2024—Responding to today’s announcement by Gilead on lenacapavir, UNAIDS Executive Director Winnie Byanyima said: “We welcome Gilead’s announcement of licensing the break-through HIV ...